CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-03 | Loerop James Chief Business Officer | Shares withheld for taxes | −5,937 | $3.47 | $21K | 192,260 |
| 2026-02-03 | Loerop James Chief Business Officer | Option exercise · Restricted Stock Units | −20,875 | 62,625 | ||
| 2026-02-03 | Walker Neal CEO | Option exercise | +63,475 | 1,562,497 | ||
| 2026-02-03 | Walker Neal CEO | Shares withheld for taxes | −18,611 | $3.47 | $65K | 1,543,886 |
| 2026-02-03 | Walker Neal CEO | Option exercise · Restricted Stock Units | −63,475 | 190,425 | ||
| 2026-02-02 | Kolbeck Roland Wilhelm Chief Scientific Officer | Grant or award · Restricted Stock Units | +95,700 | 95,700 | ||
| 2026-02-02 | Kolbeck Roland Wilhelm Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +334,900 | 334,900 | ||
| 2026-02-02 | Hall Jesse Wayne Chief Medical Officer | Grant or award · Restricted Stock Units | +98,100 | 98,100 | ||
| 2026-02-02 | Hall Jesse Wayne Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +343,300 | 343,300 | ||
| 2026-02-02 | Davis Hugh M. President and COO | Grant or award · Restricted Stock Units | +96,100 | 96,100 | ||
| 2026-02-02 | Davis Hugh M. President and COO | Grant or award · Employee Stock Option (Right to Buy) | +336,300 | 336,300 | ||
| 2026-02-02 | Balthaser Kevin Chief Financial Officer | Grant or award · Restricted Stock Units | +99,100 | 99,100 | ||
| 2026-02-02 | Balthaser Kevin Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +346,800 | 346,800 | ||
| 2026-02-02 | Loerop James Chief Business Officer | Grant or award · Restricted Stock Units | +97,700 | 97,700 | ||
| 2026-02-02 | Loerop James Chief Business Officer | Grant or award · Employee Stock Option (Right to Buy) | +341,900 | 341,900 | ||
| 2026-02-02 | Walker Neal CEO | Grant or award · Restricted Stock Units | +274,800 | 274,800 | ||
| 2026-02-02 | Walker Neal CEO | Grant or award · Employee Stock Option (Right to Buy) | +961,700 | 961,700 | ||
| 2026-02-01 | Loerop James Chief Business Officer | Option exercise | +11,250 | 165,758 | ||
| 2026-02-01 | Loerop James Chief Business Officer | Option exercise | +7,500 | 173,258 | ||
| 2026-02-01 | Loerop James Chief Business Officer | Option exercise | +14,750 | 188,008 |
Page 3 of 34 · 680 trades